Sort
82,697 grants matching “vaccine development”
Task A36: Development of Guinea Pig Immune Reagents
$841,278Tufts University Boston · N01 · FY2012 · AI
Strategic Herpesvirus Immune Evasion and Latency Defense
$841,276Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Clinical Studies on the Mechanisms of DF/DHF
$841,270Sharone Green · University Of Rhode Island · P01 · FY2011 · AI
The origin and future protective activity of SARS-CoV-2 RBD specific neutralizing antibodies
$841,228James J Kobie · University Of Alabama At Birmingham · R01 · FY2022 · AI
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$841,182Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2022 · NS
Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities
$841,023Charles T Roberts · Oregon Health & Science University · R01 · FY2021 · DK
Coronavirus vaccine development
$840,953Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID)
$840,947James Alexander Seddon · Stellenbosch University · R01 · FY2023 · AI
Alphavirus Replicon Vaccines to Encephalitis Viruses
$840,848Alphavax Human Vaccines, Inc. · U01 · FY2003 · AI
Project 2
$840,818Hanneke Schuitemaker · Beth Israel Deaconess Medical Center · U19 · FY2021 · AI
Control Systems Governing Short vs Longterm Humoral & Cellular Immunity
$840,715Christopher C Goodnow · Scripps Research Institute, The · U19 · FY2016 · AI
Prenatal factors and risk of autism in a Finnish national birth cohort
$840,697Alan Stewart Brown · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2009 · ES
Protective Immunity
$840,487David I Watkins · University Of Miami School Of Medicine · P01 · FY2015 · AI
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$840,477Afamefuna Okoye · Oregon Health & Science University · R01 · FY2023 · AI
EARLY AND REINFECTION IN HIGH RISK WOMEN
$840,402Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R37 · FY2010 · AI
Natural History of Pre-diabetic Autoimmunity (DAISY)
$840,329Marian J. Rewers · University Of Colorado Denver · R37 · FY2007 · DK
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
$840,321Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
$840,264Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Immune Memory
$840,108Rafi Ahmed · Emory University · U19 · FY2016 · AI
JAK-STAT Control of Zika Virus-Induced Fetal Injury
$840,095Kristina M Adams Waldorf · University Of Washington · R01 · FY2022 · AI
New insights into the functional diversity of the hepatic antiviral T cell response during hepacivirus infection in vivo
$840,000Eva Billerbeck · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Rift Valley Fever Vaccine Development of Animal Models and Optimize Production
$840,000Clarence J. Peters · University Of Texas Med Br Galveston · U01 · FY2008 · AI
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
$839,952Roger Keith Reeves · Beth Israel Deaconess Medical Center · R01 · FY2020 · AI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses
$839,920David E. Clements · Hawaii Biotech, Inc. · R44 · FY2019 · AI
Single-Cell Analysis of the HIV/SIV Reservoir
$839,867Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2020 · AI